Myda Advisors LLC Adaptive Biotechnologies Corp Transaction History

Myda Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$16.96 - $34.16 $661,440 - $1.33 Million	-39,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$24.56 - $32.8 $122,800 - $164,000	5,000 Added 14.71%	39,000 $1.17 Million
Q3 2019 Nov 13, 2019	BUY	$30.31 - $53.51 $500,115 - $882,915	16,500 Added 94.29%	34,000 $1.05 Million
Q2 2019 Aug 13, 2019	BUY	$40.3 - $48.3 $705,250 - $845,250	17,500 New	17,500 $845,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $797M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.